Overview
Joubert syndrome with Jeune asphyxiating thoracic dystrophy is a very rare genetic condition that combines two distinct disorders. Joubert syndrome is a brain condition where a specific part of the brain called the cerebellar vermis does not develop properly. This creates a distinctive pattern on brain MRI scans known as the 'molar tooth sign' because it looks like a cross-section of a molar tooth. This brain difference leads to problems with balance, coordination, breathing patterns, and intellectual development. Jeune asphyxiating thoracic dystrophy (also called Jeune syndrome) affects the bones, particularly the rib cage, which is abnormally small and narrow. This small chest can restrict lung growth and make breathing very difficult, especially in newborns and infants. When these two conditions occur together, children face challenges from both the brain differences and the skeletal abnormalities. Additional features may include kidney problems, liver issues, and eye abnormalities. Treatment is supportive and focuses on managing breathing difficulties, developmental therapies, and monitoring organ function. The severity can vary widely between individuals, with some children being more severely affected than others. Early intervention with physical therapy, occupational therapy, and respiratory support can help improve quality of life.
Also known as:
Key symptoms:
Abnormally small and narrow chestBreathing difficulties, especially in infancyAbnormal breathing patterns such as episodes of fast breathing or pauses in breathingLow muscle tone (floppiness)Problems with balance and coordinationDelayed motor milestones like sitting and walkingIntellectual disability of varying degreeAbnormal eye movementsShort limbs and short statureKidney problemsLiver problemsExtra fingers or toesVision problems including retinal changesDifficulty feeding in infancy
Clinical phenotype terms (50)— hover any for plain English
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Joubert syndrome with Jeune asphyxiating thoracic dystrophy.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Joubert syndrome with Jeune asphyxiating thoracic dystrophy at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Joubert syndrome with Jeune asphyxiating thoracic dystrophy.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Joubert syndrome with Jeune asphyxiating thoracic dystrophy.
Community
No community posts yet. Be the first to share your experience with Joubert syndrome with Jeune asphyxiating thoracic dystrophy.
Start the conversation →Latest news about Joubert syndrome with Jeune asphyxiating thoracic dystrophy
No recent news articles for Joubert syndrome with Jeune asphyxiating thoracic dystrophy.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.How severe is my child's chest restriction, and what respiratory support might be needed?,What does the brain MRI show, and what does this mean for my child's development?,How often should kidney and liver function be monitored?,What therapies should we start right away to support my child's development?,Are there surgical options to help expand the chest, and when would those be considered?,What is the specific genetic cause in our family, and what does this mean for future pregnancies?,Are there any clinical trials or research studies that my child might be eligible for?
Common questions about Joubert syndrome with Jeune asphyxiating thoracic dystrophy
What is Joubert syndrome with Jeune asphyxiating thoracic dystrophy?
Joubert syndrome with Jeune asphyxiating thoracic dystrophy is a very rare genetic condition that combines two distinct disorders. Joubert syndrome is a brain condition where a specific part of the brain called the cerebellar vermis does not develop properly. This creates a distinctive pattern on brain MRI scans known as the 'molar tooth sign' because it looks like a cross-section of a molar tooth. This brain difference leads to problems with balance, coordination, breathing patterns, and intellectual development. Jeune asphyxiating thoracic dystrophy (also called Jeune syndrome) affects the b
How is Joubert syndrome with Jeune asphyxiating thoracic dystrophy inherited?
Joubert syndrome with Jeune asphyxiating thoracic dystrophy follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Joubert syndrome with Jeune asphyxiating thoracic dystrophy typically begin?
Typical onset of Joubert syndrome with Jeune asphyxiating thoracic dystrophy is neonatal. Age of onset can vary across affected individuals.